Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kang Guzhengsheng capsule is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of degenerative bone and joint disorders, specifically knee osteoarthritis. Developed and evaluated by institutions such as Shuguang Hospital Affiliated to Shanghai Chinese Medical University, it is often utilized as a core component of optimized TCM regimens that may also include acupuncture, massage, and topical treatments like Fufang Zijin Xiaoshang Gao. The formulation is designed to address the underlying TCM patterns of kidney deficiency and blood stasis, which are associated with bone hyperplasia and joint degradation. Clinical research has focused on its ability to reduce pain, alleviate stiffness, and improve physical function in patients with osteoarthritis by potentially modulating inflammatory pathways and supporting bone metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kang Guzhengsheng capsule.